首页> 外文期刊>HIV medicine >Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?
【24h】

Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?

机译:高感染率的抗逆转录病毒疗法是否开始与HIV-1感染患者的CCR5 Delta32缺失有关的长期病毒学应答?

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The aim of the study was to determine whether the chemokine (C-C motif) receptor 5 (CCR5) Delta32 deletion is associated with long-term response to combination antiretroviral treatment (cART) in HIV-1-infected patients. METHODS: The genetic substudy of the Agence Nationale de Recherche sur le SIDA (ANRS) CO8 APROCO-COPILOTE cohort included 609 patients who started protease inhibitor-containing cART in 1997-1999. Patients were considered to have a sustained virological response if all plasma HIV RNA measurements in the period considered were <500 HIV-1 RNA copies/ml, allowing for a single blip. Virological response was compared between patients heterozygous for CCR5 Delta32 (Delta32/wt) and wild-type patients (wt/wt) from month 4 to year 3 and from month 4 to year 5. Logistic regression analysis was used to adjust for baseline demographical data, HIV RNA, CD4 cell count, antiretroviral exposure status, time spent on antiretroviral therapy at years 3 and 5 and adherence to treatment (month 4 to year 3 or 5). RESULTS: A sustained virological response was more frequent in Delta32/wt than in wt/wt patients from month 4 to year 3, with 66%vs. 52% of patients, respectively, showing a sustained response (P=0.02); after adjustment for potential confounders, the association of Delta32 with a sustained response was nearly significant (P=0.07). A sustained virological response was also more frequent in Delta32/wt patients up to year 5, with 48% showing a sustained response vs. 35% of wt/wt patients (P=0.01); after adjustment, Delta32 remained significantly associated with a sustained virological response up to year 5 (P=0.04). There was no association with CD4 response. CONCLUSION: The Delta32 deletion in Delta32/wt patients is associated with a beneficial virological response to cART in the long term. Whether this association is a direct effect of the Delta32 deletion remains unclear and requires confirmation in further observational studies.
机译:目的:确定趋化因子(C-C基序)受体5(CCR5)Delta32缺失与HIV-1感染患者对联合抗逆转录病毒治疗(cART)的长期反应是否相关。方法:SIDA(ANRS)CO8 APROCO-COPILOTE队列的遗传研究包括609例于1997-1999年开始使用含蛋白酶抑制剂的cART的患者。如果在考虑的期间内所有血浆HIV RNA的测量值均<500 HIV-1 RNA拷贝/ ml,则可认为患者具有持续的病毒学应答,允许进行一次检测。比较了从第4个月至第3年和第4个月至第5月对CCR5 Delta32杂合型患者(Delta32 / wt)与野生型患者(wt / wt)的病毒学应答。 ,HIV RNA,CD4细胞计数,抗逆转录病毒暴露状态,在3岁和5岁接受抗逆转录病毒治疗的时间以及坚持治疗的时间(4个月至3或5年)。结果:从第4个月到第3年,Delta32 / wt的持续病毒学应答比wt / wt的患者更为频繁,比率为66%。分别有52%的患者表现出持续反应(P = 0.02);在对潜在的混杂因素进行调整之后,Delta32与持续响应的相关性几乎很显着(P = 0.07)。直到第五年,持续的病毒学应答在Delta32 / wt患者中也更为频繁,其中48%的患者表现出持续的应答,而wt / wt患者的35%(P = 0.01);调整后,直到第5年,Delta32仍与持续的病毒学应答显着相关(P = 0.04)。与CD4反应无关。结论:长期而言,Delta32 / wt患者的Delta32缺失与对cART的有益病毒学应答有关。这种关联是否是Delta32缺失的直接影响仍不清楚,需要进一步的观察研究证实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号